| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_118720366948cfcb80fbb416398f417f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a47ab96cc1a252e2cf07688d1e5da6e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0df9ce0278f73619a7fc2e5ec7f75717
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c25facfc082256d7ed684210c2061b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ffe876bd795f7a2f2b04ffca2b9640b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-868
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-544 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate |
2011-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c867868bc22a37b1e0afaddb8d20d96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b93b26b69d4be66cde0a31b52722986
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf71f84817e867c888b156380cb26c50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_702ea5fa8cdf4afb9ce1e7e0ec399653 |
| publicationDate |
2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012128759-A1 |
| titleOfInvention |
Method to inhibit airway hyperresponsiveness using aerosolized t cell receptor antibodies |
| abstract |
Disclosed is a method to reduce airway hyperresponsivesness in an animal by the direct delivery to the lungs of aerosolized antibodies against T cell receptors. The method is particularly useful for treating airway hyperresponsiveness associated with allergic inflammation, is effective at extremely low doses of antibody, and does not have a substantial effect on the peripheral immune system. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013174846-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8701663-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9655544-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11154217-B2 |
| priorityDate |
2001-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |